Boscogen Overseas Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 01-06-2024
- Paid Up Capital ₹ 1.94 M
as on 01-06-2024
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 3.50 M
as on 01-06-2024
About Boscogen Overseas
The Corporate was formerly known as Boscogen Biosciences (India) Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.94 M.
The company has closed loans amounting to ₹3.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vivek Hundlani, Sandeep Ahuja, and Sandhya Hundlani serve as directors at the Company.
- CIN/LLPIN
U51909GJ1994PLC023972
- Company No.
023972
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Dec 1994
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Boscogen Overseas?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Hundlani  | Director | 25-Jan-2006 | Current |
| Sandeep Ahuja | Director | 01-May-2019 | Current |
| Sandhya Hundlani | Additional Director | 25-Nov-2008 | Current |
Financial Performance and Corporate Structure Insights of Boscogen Overseas.
Boscogen Overseas Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Boscogen Overseas?
In 2017, Boscogen Overseas had a promoter holding of 36.72% and a public holding of 63.28%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Regent Healthcare LimitedActive 18 years 10 monthsVivek Hundlani, Sandeep Ahuja and 1 more are mutual person
- Cosmos Remedies LimitedActive 28 years 7 months
Vivek Hundlani, Sandeep Ahuja and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 10 Jan 2006 | ₹2.50 M | Satisfied |
Dena Bank Creation Date: 16 Dec 1997 | ₹1.00 M | Satisfied |
How Many Employees Work at Boscogen Overseas?
Unlock and access historical data on people associated with Boscogen Overseas, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Boscogen Overseas, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Boscogen Overseas's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
